Skip to main content

Table 1 Presenting features of 404 ART naïve adults in care at Themba Lethu in Johannesburg, South Africa stratified by KSHV&status

From: Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa

Characteristics#

 

* General Clinic Population (n = 679)

KSHV+&(n = 193)

KSHV-&(n = 211)

Female

 

416 (61%)

127 (66%)

135 (64%)

Age (yrs.)

Median (IQR)

37 (31-43)

37 (32-47)

38 (32-45)

WHO Stage

I/II

408 (64%)

116 (64%)

114 (61%)

(n, %)

III/IV

231 (36%)

64 (36%)

74 (39%)

BMI

< 18.5

118 (23%)

38 (21%)

57 (29%)

(n, %)

18.5-24.9

286 (56%)

98 (56%)

94 (48%)

 

25-30

72 (14%)

23 (13%)

31 (16%)

 

> 30

37 (7%)

15 (8%)

14 (7%)

Hemoglobin (n, %)

≤ 8.0 g/dL

41 (7%)

14 (7%)

13 (6%)

CD4 count (cells/mm3)

Median (IQR)

100 (39-173)

101 (46-168)

89 (34-164)

CD4 cell count category

0-50

167 (31%)

47 (28%)

63 (34%)

(n, %)

51-100

106 (19%)

39 (23%)

39 (21%)

 

101-200

182 (33%)

65 (38%)

56 (30%)

 

200-350

89 (16%)

20 (12%)

30 (16%)

Tuberculosis (n, %)

Yes

75 (11%)

26 (14%)

30 (15%)

HIV RNA

Median (IQR)

20000 (8300-39000)

15500 (6400-33500)

19500 (7300-39000)

  1. # Characteristics at eligibility for initiation of antiretroviral therapy
  2. * Themba Lethu clinic general population refers to treatment naïve adults eligible for initiation of antiretroviral therapy during the study period who were not recruited into the study
  3. &KSHV = Kaposi sarcoma herpes virus